Skip to Main Content

Paper Details

Nivolumab Plus Ipilimumab in Patients With Solid Tumors With <i>ATM</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
JCO Precis Oncol
1
2023
Author NameAffiliation
Funda Meric-BernstamUniversity of Texas MD Anderson Cancer Center
  • 1 - 1

Datasets

Release 1.2